Literature DB >> 2827371

Scar and non-scar ductal cancer of the female breast. Observations on patient age, tumour size, and hormone receptors.

S Partanen1, H Hyvärinen.   

Abstract

Ductal cancers of human female breasts were classified as scar or non-scar type. Of 274 cancers, 144 were scar and 130 non-scar type. Estrogen and progesterone receptors were determined in 191 cases; the cancer was classified as hormone receptor positive if either the estrogen or progesterone receptor level, or both, was over 10 fmol/mg of cytosol protein. The mean age of patients with scar cancer was higher than that of patients with non-scar cancer (59.8 +/- 13.5 and 49.4 +/- 12.0 years, respectively, p less than 0.001). A higher number of hormone receptor positive cases was found among the scar than among the non-scar cancers (68 of 94 and 48 of 97 cases, respectively, p less than 0.01). Within the two groups, the patient's age was not associated with hormone receptor status. Our results indicate that the generally observed tendency for postmenopausal breast cancer to be more often hormone receptor positive than premenopausal cancer may be associated with the histological type and not with the patient's age. Scar cancers were also smaller than 2 cm more frequently than non-scar cancers (p less than 0.001) and as a group, ductal cancers were smaller in postmenopausal patients than in premenopausal patients (p = 0.088). Again, this tendency seemed to be linked with the type of cancer rather than with the patient's age.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2827371     DOI: 10.1007/BF00716186

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  21 in total

1.  Sclerosing papillary proliferations in the female breast. A benign lesion often mistaken for carcinoma.

Authors:  C Fenoglio; R Lattes
Journal:  Cancer       Date:  1974-03       Impact factor: 6.860

2.  Breast carcinoma. Aspects of early stages, progression and related problems.

Authors:  F Linell; O Ljungberg; I Andersson
Journal:  Acta Pathol Microbiol Scand Suppl       Date:  1980

Review 3.  Estrogen receptors and breast cancer.

Authors:  J L Stanford; M Szklo; L A Brinton
Journal:  Epidemiol Rev       Date:  1986       Impact factor: 6.222

4.  [Radial scars (scarring) and obliterating mastopathy (author's transl)].

Authors:  H Hamperl
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1975-12-29

5.  Steroid-hormone receptors in breast cancer.

Authors:  J L Wittliff
Journal:  Cancer       Date:  1984-02-01       Impact factor: 6.860

6.  Correlation of hormone receptors with pathological features in human breast cancer.

Authors:  R R Millis
Journal:  Cancer       Date:  1980-12-15       Impact factor: 6.860

7.  Correlation of estrogen receptor and pathologic characteristics of invasive breast cancer.

Authors:  E R Fisher; C K Redmond; H Liu; H Rockette; B Fisher
Journal:  Cancer       Date:  1980-01-15       Impact factor: 6.860

8.  Cell proliferation in normal human breast ducts, fibroadenomas, and other ductal hyperplasias measured by nuclear labeling with tritiated thymidine. Effects of menstrual phase, age, and oral contraceptive hormones.

Authors:  J S Meyer
Journal:  Hum Pathol       Date:  1977-01       Impact factor: 3.466

9.  Estrogen and progesterone receptors in breast carcinoma: correlations with epidemiology and pathology.

Authors:  M L Lesser; P P Rosen; R T Senie; K Duthie; C Menendez-Botet; M K Schwartz
Journal:  Cancer       Date:  1981-07-15       Impact factor: 6.860

10.  Elastosis and oestrogen receptors in human breast cancer.

Authors:  J R Masters; K Sangster; R A Hawkins; A A Shivas
Journal:  Br J Cancer       Date:  1976-03       Impact factor: 7.640

View more
  2 in total

1.  Breast cancer stromal elastosis is associated with mammography screening detection, low Ki67 expression and favourable prognosis in a population-based study.

Authors:  Ying Chen; Tor A Klingen; Elisabeth Wik; Hans Aas; Einar Vigeland; Knut Liestøl; Øystein Garred; Jan Mæhlen; Lars A Akslen; Jon Lømo
Journal:  Diagn Pathol       Date:  2014-12-19       Impact factor: 2.644

2.  Fibrotic focus in invasive ductal carcinoma: an indicator of high tumor aggressiveness.

Authors:  T Hasebe; H Tsuda; S Hirohashi; Y Shimosato; M Iwai; S Imoto; K Mukai
Journal:  Jpn J Cancer Res       Date:  1996-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.